6505-00-584-2895 ( NDC50111-0327-03 , NDC00083-0039-40 , NDC49884-0027-10 , NDC50111-0327-03 , NDC49884-0027-10 , APRESOLINE , NDC00364-0144-02 , NDC00005-3564-34 , NDC00182-0554-10 )
NSN Information
NSN | FSC | NIIN | Item Name | INC |
---|---|---|---|---|
6505-00-584-2895 | 6505 | 005842895 | HYDRALAZINE HYDROCHLORIDE TABLET | 0951 |
NSN Features
MRC | Parameter | Characteristics |
---|---|---|
ECWT | EXTERIOR CONTAINER WEIGHT | 54.00 POUNDS |
EXME | EXTERIOR CONTAINER CUBIC MEASURE | 1.20 CUBIC FEET |
EXQT | EXTERIOR CONTAINER QUANTITY | 48 |
SUWT | UNIT OF ISSUE WEIGHT | 0.69 POUNDS |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
PKQT | INTERMEDIATE PACKAGE QUANTITY | 12 |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 TABLETS |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS HYDRALAZINE HYDROCHLORIDE ACTIVE INGREDIENT |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | HYDRALAZINE HYDROCHLORIDE TABLETS USP 25 MG 1000S |
SUCB | UNIT OF ISSUE CUBE | 0.023 CUBIC FEET |
SUPP | SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |
Manufacturing Part Numbers (SKUs)
Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
---|---|---|---|---|---|---|---|
NDC50111-0327-03 | 1BL76 | A | 2 | 5 | 4 | ZZ | |
NDC00083-0039-40 | 04482 | A | 9 | 5 | 6 | 54 | |
NDC49884-0027-10 | 0VZ14 | A | 2 | 3 | 4 | ZZ | |
NDC50111-0327-03 | 0A423 | A | 2 | 5 | 4 | ZZ | |
NDC49884-0027-10 | 61903 | F | 9 | 5 | 4 | ZZ | |
APRESOLINE | 04482 | A | 1 | 5 | 6 | 54 | |
NDC00364-0144-02 | 0PTT8 | A | 2 | 5 | 4 | ZZ | |
NDC00005-3564-34 | 06404 | A | 2 | 3 | 6 | 54 | |
NDC00182-0554-10 | 63488 | A | 9 | 5 | 4 | ZZ |
Manufacturers
Part SKU | Cage | Manufacturer | Type | Status |
---|---|---|---|---|
NDC50111-0327-03 | 1BL76 | SIDMAK LABORATORIES INC | F | A |
NDC00083-0039-40 | 04482 | CIBA-GEIGY CORP | A | A |
NDC49884-0027-10 | 0VZ14 | PAR PHARMACEUTICAL INC. | F | A |
NDC50111-0327-03 | 0A423 | CARDINAL HEALTH 100 INC | F | A |
NDC49884-0027-10 | 61903 | PAR PHARMACEUTICAL INC | A | F |
APRESOLINE | 04482 | CIBA-GEIGY CORP | A | A |
NDC00364-0144-02 | 0PTT8 | SCHEIN PHARMACEUTICAL INC | A | A |
NDC00005-3564-34 | 06404 | AMERICAN CYANAMID CO | A | A |
NDC00182-0554-10 | 63488 | GOLDLINE LABORATORIES INC. | A | A |
FLIS Identification
PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
---|---|---|---|---|---|---|---|---|---|---|
A | X | A | 01/01/1 | P | 3004909120 | 0951 |
FLIS Management
MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
---|---|---|---|---|---|
DF | ------- | F | K | U/I CONTAINS 1000 TT | |
DM | Z | 1354--1 | M | K | U/I CONTAINS 1000 TT |
DN | 9B----- | N | K | U/I CONTAINS 1000 TT | |
DA | C2201X- | A | K | U/I CONTAINS 1000 TT | |
VA | V | K | U/I CONTAINS 1000 TT | ||
DS | N | I | K | U/I CONTAINS 1000 TT |
Demilitarization Codes & Management
DML | PMI | HMIC | ADP | CC | ESDC |
---|---|---|---|---|---|
A | A | P | X |
Miscellaneous Management
MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
---|---|---|---|---|---|---|---|---|---|
DN | SMS | L | 1 | BT | R | U | 9B----- | N | |
DF | SMS | L | 1 | BT | R | U | ------- | F | |
DA | SMS | L | 1 | BT | R | U | C2201X- | A | |
DS | SMS | L | 1 | BT | R | U | D | ||
VA | I | 1 | BT | Q | U | V | |||
DM | SMS | L | 1 | BT | R | U | Z | 1354--1 | M |
Management Control Army
MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
---|---|---|---|---|
C | 2 | 2 | 01 | X |
Freight
NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
---|---|---|---|---|---|---|---|---|---|---|---|---|
058770 | Z | 33400 | W | 532 | H | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |